1.Increase in the Level of Proinflammatory Cytokine HMGB1 in Nasal Fluids of Patients With Rhinitis and its Sequestration by Glycyrrhizin Induces Eosinophil Cell Death.
Leonardo CAVONE ; Caterina CUPPARI ; Sara MANTI ; Luisa GRASSO ; Teresa ARRIGO ; Luca CALAMAI ; Carmelo SALPIETRO ; Alberto CHIARUGI
Clinical and Experimental Otorhinolaryngology 2015;8(2):123-128
OBJECTIVES: The nuclear protein high mobility group protein box 1 (HMGB1) is a proinflammatory mediator that belongs to the alarmin family of proinflammatory mediators, and it has recently emerged as a key player in different acute and chronic immune disorders. Several lines of evidence demonstrate that HMGB1 is actively released extracellularly from immune cells or passively released from necrotic cells. Because of the ability of HMGB1 to sustain chronic inflammation, we investigated whether the protein is present in nasal fluids of patients with different forms of rhinitis. METHODS: HMGB1 levels were evaluated in nasal fluids of healthy subjects or rhinitis patients who were treated or not treated with different treatments. RESULTS: We report that the level of HMGB1 was significantly increased in nasal fluids of patients with allergic rhinitis, patients with NARES (nonallergic rhinitis with eosinophiliac syndrome), as well as patients with polyps. We also found that a formulation containing the HMGB1-binding compound glycyrrhizin (GLT) reduced the HMGB1 content in nasal fluids of rhinitis patients to an extent similar to that with nasal budesonide treatment. We also found that among the cultured human leukocyte populations, eosinophils released higher amounts of HMGB1. Based on the ability of HMGB1 to sustain eosinophil survival and the ability of GLT to inactivate HMGB1, we report that GLT selectively killed cultured eosinophils and had no effect on neutrophils, macrophages, and lymphocytes. CONCLUSION: Collectively, these data underscore the role of HMGB1 in rhinitis pathogenesis and the therapeutic potential of GLT formulations in treatment of chronic inflammatory disorders of the nasal mucosa.
Budesonide
;
Cell Death*
;
Eosinophils*
;
Glycyrrhizic Acid*
;
HMGB1 Protein*
;
Humans
;
Immune System Diseases
;
Inflammation
;
Leukocytes
;
Lymphocytes
;
Macrophages
;
Nasal Mucosa
;
Neutrophils
;
Nuclear Proteins
;
Polyps
;
Rhinitis*
2.Lack of methylation changes in GJB2 and RB1 non-coding regions of cochlear implant patients with sensorineural hearing loss
Angelo Augusto M. Sumalde ; Ivana V. Yang ; Talitha Karisse L. Yarza ; Celina Ann M. Tobias-Grasso ; Ma. Leah C. Tantoco ; Elizabeth Davidson ; Abner L. Chan ; Mahshid S. Azamian ; Teresa Luisa G. Cruz ; Seema R. Lalani ; Maria Rina T. Reyes-Quintos ; Eva Maria Cutiongco-de la Paz ; Regie Lyn P. Santos-Cortez ; Charlotte M. Chiong
Acta Medica Philippina 2023;57(9):116-120
Objective:
Recent advances in epigenetic studies continue to reveal novel mechanisms of gene regulation and control, however little is known on the role of epigenetics in sensorineural hearing loss (SNHL) in humans. We aimed to investigate the methylation patterns of two regions, one in RB1 and another in GJB2 in Filipino patients with SNHL compared to hearing control individuals.
Methods:
We investigated an RB1 promoter region that was previously identified as differentially methylated in children with SNHL and lead exposure. Additionally, we investigated a sequence in an enhancer-like region within GJB2 that contains four CpGs in close proximity. Bisulfite conversion was performed on salivary DNA samples from 15 children with SNHL and 45 unrelated ethnically-matched individuals. We then performed methylation-specific real-time PCR analysis (qMSP) using TaqMan® probes to determine percentage methylation of the two regions.
Results:
Using qMSP, both our cases and controls had zero methylation at the targeted GJB2 and RB1 regions.
Conclusion
Our study showed no changes in methylation at the selected CpG regions in RB1 and GJB2 in the two comparison groups with or without SNHL. This may be due to a lack of environmental exposures to these target regions. Other epigenetic marks may be present around these regions as well as those of other HL-associated genes.
Hearing Loss
;
Methylation